Leave it in the past – primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
To compare outcomes of patients with high-grade epithelial ovarian cancer (EOC) who underwent...
Read More